Cell line-specific impact of dexamethasone on the bioprocessing of Chinese hamster ovary cells
- 23 April 2024
- journal article
- research article
- Published by Springer Nature in Biotechnology and Bioprocess Engineering
- Vol. 29 (4) , 699-711
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and ICT, South Korea (2021R1F1A1050904)
- Ministry of Trade, Industry and Energy (20008853)
- Ministry of Education (RIS, 2022RIS-005)
This publication has 53 references indexed in Scilit:
- Multi‐omics profiling of CHO parental hosts reveals cell line‐specific variations in bioprocessing traitsBiotechnology and Bioengineering, 2019
- Bioprocessing of Recombinant CHO-K1, CHO-DG44, and CHO-S: CHO Expression Hosts Favor Either mAb Production or Biomass SynthesisBiotechnology Journal, 2018
- Intracellular response to process optimization and impact on productivity and product aggregates for a high‐titer CHO cell processBiotechnology and Bioengineering, 2017
- Valeric acid induces cell cycle arrest at G1 phase in CHO cell cultures and improves recombinant antibody productivityBiotechnology Journal, 2015
- An 'omics approach towards CHO cell engineeringBiotechnology and Bioengineering, 2013
- A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodiesBiotechnology and Bioengineering, 2011
- Sialylation enhancement of CTLA4‐Ig fusion protein in Chinese hamster ovary cells by dexamethasoneBiotechnology and Bioengineering, 2010
- A study of monoclonal antibody‐producing CHO cell lines: What makes a stable high producer?Biotechnology and Bioengineering, 2008
- Proteome analysis of antibody‐producing CHO cell lines with different metabolic profilesBiotechnology and Bioengineering, 2007
- Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressureBiotechnology and Bioengineering, 1998